NEWSROOM

Welcome to the Pharmaceutical Care Management Association’s Newsroom where you can access PCMA’s latest media statements and learn more about pharmacy benefit managers’ efforts to reduce costs and increase access on prescription medications for the more than 210 million Americans.

For media or other inquiries, please contact:
Charles Coté, Senior Director of Public Affairs 202-207-3605

March 2010

03.10.2010

Survey of Federal Employees Regarding FEHBP Drug Benefit

03.01.2010

PCMA: New GAO Report Highlights the Need for Meaningful Biogenerics Reform

February 2010

02.23.2010

Proposed Overhaul of FEHBP Pharmacy Benefit Would Undermine Cost-Saving Tools, Reduce Choices for 8 Million Americans

02.23.2010

H.R. 4489, the “FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act” — PCMA Statement for the Record

02.11.2010

Pharma Executive Perspectives to be Highlight of Upcoming PBM Summit

January 2010

01.21.2010

PCMA Statement: Wrong Time for Congress to Experiment On The Federal Employees Health Benefits Program

01.14.2010

New Study: Mail-Service Pharmacies Likely To Improve Prescription Drug Adherence

01.11.2010

New GAO Study: Lack of Competition Helping Drive ‘Extraordinary’ Brand-Name Drug Price Increases

01.05.2010

PCMA: Proven PBM Tools Help Drive Historic Slowdown in Prescription Drug Spending

December 2009

12.16.2009

PCMA: Don’t Tax Prescription Drug Benefits To Pay for Health Reform

November 2009

11.24.2009

PCMA Letter to U.S. Senate Majority Leader Reid

11.18.2009

PCMA Appoints Jerry Steffl Vice President of Federal Affairs

11.17.2009

PCMA: Butterfield Bill Would Increase Pharmacy Costs, Undermine Unions and Employers

11.16.2009

PCMA: Real Biogenerics Reform, Not Pharma Deal ‘Shell Games,’ Will Lower Drug Costs

October 2009

10.15.2009

New England Journal of Medicine Article: Biogenerics Legislation Should Grant 5 Years Exclusivity

10.08.2009

Want to Lower Prescription Drug Costs? Try Generics and Mail-Service Pharmacies

September 2009

09.25.2009

Senate Finance Committee ‘Disclosure’ Amendment Will Increase Prescription Drug Costs

09.23.2009

PCMA Urges Senate Finance Committee to Help Make Prescription Drugs More Affordable for All Americans

09.18.2009

NCPA ‘Poll’ Contradicts J.D. Power and Associates Survey on Mail-Service Pharmacy

09.17.2009

New J.D. Power and Associates Study Finds Consumer Satisfaction with Pharmacy Options

09.16.2009

PCMA: Baucus Health Reform Plan Sustains Proven PBM Delivery Model Yielding Expanded Access, Lower Costs

09.10.2009

PCMA: Improving Affordability Critical to Reforming Health Care

July 2009

07.31.2009

PCMA Statement on U.S. House Energy and Commerce Committee Health Care Reform Markup

07.30.2009

PCMA: New Study Highlights ‘Market-Based’ Reforms to Lower Part D Drug Prices

07.16.2009

PCMA: Real Reform Requires a Level Playing Field

07.16.2009

PCMA Letter to the U.S. House of Representatives Tri-Committee on the “America’s Affordable Health Choices Act of 2009”

07.16.2009

PCMA Written Testimony to the U.S. Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Insurance: “Competition in the Health Care Marketplace”

07.14.2009

PCMA Vows Continued Support for Real Biogenerics Reform Despite Committee Vote

07.09.2009

New PCMA Ad on Biogenerics: ‘Bio-Illogic’

07.09.2009

New PCMA Ad on Biogenerics

07.06.2009

PCMA on Biogenerics Legislation: A Bellwether for Broader Health Reform Prospects

June 2009

06.25.2009

PCMA Launches New Biogenerics Ad

06.15.2009

PCMA: President Obama, MedPAC Call for Follow-On Biologics

06.13.2009

PCMA Statement on the Administration’s Comments Regarding Financing Health Care Reform

06.10.2009

PCMA: New FTC Report Confirms Additional Exclusivity Periods for Biologics Harms Competition

06.09.2009

PCMA Statement on Baucus-Conrad Comparative Effectiveness Legislation

06.02.2009

PCMA on New GAO Report: Shows Urgent Need for Biogenerics Legislation

May 2009

05.07.2009

PCMA: New National Generic Pharmaceutical Study Finds Savings of $734 Billion Over the Last Decade

April 2009

04.10.2009

PCMA: New Blue Cross/Blue Shield Prescription-Drug Survey Confirms Generic Drugs Have Gone Mainstream With Consumers, Doctors & Payers

04.02.2009

PCMA Launches New Ad Campaign: ‘Waiting Isn’t An Option’ for Biogenerics

04.02.2009

New PCMA Biogenerics Ad: “Waiting Isn’t An Option”